FDA to scrutinize 30 compounders in 2 months

03/3/2013 | Bloomberg Businessweek

The FDA plans to inspect around 30 drug compounders in the next two months as part of heightened efforts following a deadly meningitis outbreak tied to compounded drugs. The pharmacies mainly produce sterile drugs for health care providers across the country, FDA spokeswoman Erica Jefferson said.

View Full Article in:

Bloomberg Businessweek

Published in Brief: